|Other Names||Heat shock protein beta-8, HspB8, Alpha-crystallin C chain, E2-induced gene 1 protein, Protein kinase H11, Small stress protein-like protein HSP22, HSPB8, CRYAC, E2IG1, HSP22|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP7139a was selected from the N-term region of human HSPB8. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Synonyms||CRYAC, E2IG1, HSP22|
|Function||Displays temperature-dependent chaperone activity.|
|Cellular Location||Cytoplasm. Nucleus. Note=Translocates to nuclear foci during heat shock|
|Tissue Location||Predominantly expressed in skeletal muscle and heart.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Heat-shock protein beta-8 (HSPB8) displays temperature-dependent chaperone activity. It acts as a Mn(2+)-dependent serine-threonine-specific protein kinase. Defects in HSPB8 are a cause of distal hereditary motor neuropathy type II ; also known as distal spinal muscular atrophy and spinal muscular atrophy of the Charcot-Marie-Tooth type. It is also an autosomal dominant disorder of lower motor neurons characterized by distal muscle weakness.
Irobi, J., et al., Nat. Genet. 36(6):597-601 (2004).Gober, M.D., et al., J. Biol. Chem. 278(39):37600-37609 (2003).Depre, C., et al., Circ. Res. 91(11):1007-1014 (2002).Benndorf, R., et al., J. Biol. Chem. 276(29):26753-26761 (2001).Kappe, G., et al., Biochim. Biophys. Acta 1520(1):1-6 (2001).
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.